Middle East & Africa Acromegaly Treatment Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$54.2

Forecast, 2030 (US$M)

$80.7

CAGR, 2024 - 2030

5.9%

Report Coverage

Middle East & Africa

Middle East & Africa acromegaly treatment market, 2018-2030 (US$M)

Related Markets

Global Acromegaly Treatment Industry

North America Acromegaly Treatment Market Outlook

Europe Acromegaly Treatment Market Outlook

Asia Pacific Acromegaly Treatment Market Outlook

Latin America Acromegaly Treatment Market Outlook

MEA acromegaly treatment market highlights

The MEA acromegaly treatment market generated a revenue of USD 54.2 million in 2023.
The market is expected to grow at a CAGR of 5.8% from 2024 to 2030.
In terms of segment, hospitals & clinics was the largest revenue generating end use in 2023.
Hospitals & Clinics is the most lucrative end use segment registering the fastest growth during the forecast period.

MEA data book summary

Market revenue in 2023	USD 54.2 million
Market revenue in 2030	USD 80.7 million
Growth rate	5.8% (CAGR from 2023 to 2030)
Largest segment	Hospitals & clinics
Fastest growing segment	Hospitals & Clinics
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Hospitals & Clinics
Key market players worldwide	Novartis AG ADR, Ipsen SA, Sun Pharmaceutical Industries, Wockhardt, Dauntless Pharmaceuticals, Pfizer Inc, Ionis Pharmaceuticals Inc

Other key industry trends

In terms of revenue, MEA region accounted for 4.1% of the global acromegaly treatment market in 2023.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 398.7 million by 2030.

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Acromegaly Treatment Market Scope

Acromegaly treatment market segmentation & scope

End Use

Hospitals & Clinics

Others

Regions

Europe

Countries

U.S.

Canada

Germany

France

Italy

Spain

Denmark

Sweden

Norway

China

India

Japan

Australia

Thailand

South Korea

Brazil

Mexico

Argentina

Saudi Arabia

South Africa

UAE

Kuwait

Acromegaly Treatment Market Companies

Name	Profile	# Employees	HQ	Website

Middle East & Africa acromegaly treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to acromegaly treatment market will help companies and investors design strategic landscapes.

Hospitals & clinics was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Middle East & Africa acromegaly treatment market based on hospitals & clinics covering the revenue growth of each sub-segment from 2018 to 2030.

Middle East & Africa Acromegaly Treatment End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Clinics
- Others

Reasons to subscribe to Middle East & Africa acromegaly treatment market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa acromegaly treatment market databook

Our clientele includes a mix of acromegaly treatment market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa acromegaly treatment market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa acromegaly treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list